Citation Information :
Srinivasan R, Dey P, Prasad G, Rajwanshi A, Gupta N, Siwatch S, Ghoshal S, Rai B, Madan R, Chowdhary A, Gude G, Jain V, Rohilla M. Fertility Sparing Management in Carcinoma Endometrium. J Postgrad Med Edu Res 2017; 51 (3):152-153.
Prognostic factors for uterine cancers in reproductive age women. Obstet Gynecol 2007 Mar;109(3):655-662.
Endometrial cancer treatment Physician Data Query (PDQ) 2015; http://www.cancer.gov/cancertopics/pdq/treatment/endometrial/healthprofessional (last accessed 1 April 2015).
Endometrial cancer in women 40 years old or younger. Gynecol Oncol 2001 Nov;83(2):388-393.
Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998 Mar;91(3):349-354.
Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women. Ann Oncol 2011 Mar;22(3):643-649.
Int J Gynecol Cancer 2015 Sep;25(7):1258-1265.
Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma. Gynecol Oncol 2009 Apr;113(1):105-108.
Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999 Sep;212(3):711-718.
Comparison of dilatation & curettage and endometrial aspiration biopsy accuracy in patients treated with high-dose oral progestin plus levonorgestrel intrauterine system for early-stage endometrial cancer. Gynecol Oncol 2013 Sep;130(3):470-473.
Regression, relapse, and live birth rates with fertility-sparing therapy for endometrial cancer and atypical complex endometrial hyperplasia: a systematic review and metaanalysis. Am J Obstet Gynecol 2012 Oct;207(4):266.e1-266.e12.